Drug-tolerant persisters to TRAIL emerge from a dose-dependent surface in a cell-state continuum of sensitivity
Abstract
Clonal cancer cells show heterogeneous responses to cytotoxic drugs, raising the question of whether this variability reflects discrete phenotypes or a continuum of underlying cell states. We address this by quantifying single-cell caspase-8 activation dynamics after TRAIL treatment and developing an extended mechanistic model of the extrinsic apoptosis pathway that incorporates c-FLIP-mediated control of initiator caspase activation. Fitting this model to individual trajectories across multiple doses recovers cell-specific procaspase-8 and c-FLIP abundances, together with three kinetic parameters, and reproduces the full diversity of observed responses. Embedding these inferred parameters into a shared state space reveals that sensitive and tolerant outcomes do not correspond to discrete subpopulations. Instead, a single biochemical pathway generates a continuous distribution of cell states whose position at treatment determines fate. Linking each trajectory to its early activation rate identifies a dose-dependent hyperplane that partitions this landscape into apoptotic and tolerant regions. Increasing drug dose translates this decision surface predictably, altering the outcome only for cells positioned near the boundary. This geometric perspective explains fractional killing in clonal populations and shows how drug-tolerant persister cells can arise from reversible variation in cell state. It further suggests that shifting state-space distributions relative to the decision surface may offer new strategies to limit persistence.
Related
- Dose-dependent sensitivity of human three-dimensional chromatin to a heart disease–linked transcription factor
- Insulin enhances RAGE ectodomain shedding by inducing Rab14-dependent ADAM10 cell surface trafficking in human aortic endothelial cells
- Deletion of sc3, Alone or in Combination with sc15, Alters Mycelial Surface Wettability and Substrate-Dependent Adhesion in Schizophyllum commune
- NoiBic: a noise-tolerant biclustering algorithm for high-throughput gene expression data analysis.
- Environment-Tolerant Blinking Fluorophores Enable Dual-Color Super-Resolution Correlative Light and Electron Microscopy
BibTeX
@article{fiandaca2026drugtolerant,
title = {{Drug-tolerant persisters to TRAIL emerge from a dose-dependent surface in a cell-state continuum of sensitivity}},
author = {Giada Fiandaca and Marielle Péré and Kelian Bonhomme and Madalena Chaves and Jérémie Roux},
journal = {npj Systems Biology and Applications},
year = {2026},
month = jul,
doi = {10.1038/s41540-026-00782-4},
url = {https://hal.science/hal-05763971v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Drug-tolerant persisters to TRAIL emerge from a dose-dependent surface in a cell-state continuum of sensitivity
AU - Giada Fiandaca
AU - Marielle Péré
AU - Kelian Bonhomme
AU - Madalena Chaves
AU - Jérémie Roux
PY - 2026
DA - 2026/07/13
JO - npj Systems Biology and Applications
DO - 10.1038/s41540-026-00782-4
UR - https://hal.science/hal-05763971v1
AB - Clonal cancer cells show heterogeneous responses to cytotoxic drugs, raising the question of whether this variability reflects discrete phenotypes or a continuum of underlying cell states. We address this by quantifying single-cell caspase-8 activation dynamics after TRAIL treatment and developing an extended mechanistic model of the extrinsic apoptosis pathway that incorporates c-FLIP-mediated control of initiator caspase activation. Fitting this model to individual trajectories across multiple doses recovers cell-specific procaspase-8 and c-FLIP abundances, together with three kinetic parameters, and reproduces the full diversity of observed responses. Embedding these inferred parameters into a shared state space reveals that sensitive and tolerant outcomes do not correspond to discrete subpopulations. Instead, a single biochemical pathway generates a continuous distribution of cell states whose position at treatment determines fate. Linking each trajectory to its early activation rate identifies a dose-dependent hyperplane that partitions this landscape into apoptotic and tolerant regions. Increasing drug dose translates this decision surface predictably, altering the outcome only for cells positioned near the boundary. This geometric perspective explains fractional killing in clonal populations and shows how drug-tolerant persister cells can arise from reversible variation in cell state. It further suggests that shifting state-space distributions relative to the decision surface may offer new strategies to limit persistence.
SN - 2056-7189
ER -